Cargando…

LGMD D2 TNPO3-Related: From Clinical Spectrum to Pathogenetic Mechanism

Limb-girdle muscular dystrophies (LGMDs) are clinically and genetically heterogeneous diseases presenting with a wide clinical spectrum. Autosomal dominant LGMDs represent about 10–15% of LGMDs and include disorders due to defects of DNAJB6, transportin-3 (TNPO3), HNRNPDL, Calpain-3 (CAPN3), and Bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Roberta, Rodia, Maria Teresa, Pacilio, Serafina, Angelini, Corrado, Cenacchi, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931187/ https://www.ncbi.nlm.nih.gov/pubmed/35309568 http://dx.doi.org/10.3389/fneur.2022.840683

Ejemplares similares

Morphological study of TNPO3 and SRSF1 interaction during myogenesis by combining confocal, structured illumination and electron microscopy analysis
por: Costa, Roberta, et al.
Publicado: (2021)

Electrospun Poly(L-lactide-co-ε-caprolactone) Scaffold Potentiates C2C12 Myoblast Bioactivity and Acts as a Stimulus for Cell Commitment in Skeletal Muscle Myogenesis
por: Pacilio, Serafina, et al.
Publicado: (2023)

Proceedings of the XI Congress of the Italian Association of Myology Cagliari, May 2011: LGMD 1(F) - A pathogenetic hypothesis based on histopathology and ultrastructure
por: Cenacchi, G., et al.
Publicado: (2011)

LGMD. Identification, description and classification
por: Angelini, Corrado
Publicado: (2020)

Long term follow-up and further molecular and histopathological studies in the LGMD1F sporadic TNPO3-mutated patient
por: Gibertini, Sara, et al.
Publicado: (2018)

LGMD phenotype due to a new gene and dysferlinopathy investigated by next-generation sequencing
por: Angelini, Corrado I.
Publicado: (2015)

The Role of TNPO3 in HIV-1 Replication
por: Diaz-Griffero, Felipe
Publicado: (2012)

A female case report of LGMD2B with compound heterozygous mutations of the DYSF gene and asymptomatic mutation of the X-linked DMD gene
por: Cao, Xiaojie, et al.
Publicado: (2023)

Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing
por: Yu, Meng, et al.
Publicado: (2017)

The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance
por: Menozzi, Elisa, et al.
Publicado: (2021)

Editorial: Advances in understanding the pathogenetic mechanisms of neurodevelopmental disorders and neurodegenerative disease — The environment as a putative risk factor
por: Lavezzi, Anna Maria, et al.
Publicado: (2023)

Next-Generation Sequencing Identifies Transportin 3 as the Causative Gene for LGMD1F
por: Torella, Annalaura, et al.
Publicado: (2013)

Current and Future Approaches to Classify VUSs in LGMD-Related Genes
por: Li, Chengcheng, et al.
Publicado: (2022)

Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations
por: Savarese, Marco, et al.
Publicado: (2015)

Disease Progression and Mutation Pattern in a Large Cohort of LGMD R1/LGMD 2A Patients from India
por: Ganaraja, Valakunja H., et al.
Publicado: (2021)

Lipolysis and lipophagy in lipid storage myopathies
por: Angelini, Corrado, et al.
Publicado: (2016)

Diagnostically important muscle pathology in DNAJB6 mutated LGMD1D
por: Sandell, Satu, et al.
Publicado: (2016)

Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations
por: Finsterer, Josef
Publicado: (2018)

Tnpo3 enables EBF1 function in conditions of antagonistic Notch signaling
por: Bayer, Marc, et al.
Publicado: (2022)

LGMD2I in a North American population
por: Kang, Peter B, et al.
Publicado: (2007)

Tail properties and approximate distribution and expansion for extreme of LGMD
por: Huang, Jianwen, et al.
Publicado: (2017)

Neurocutaneous Melanosis in Association With Large Congenital Melanocytic Nevi in Children: A Report of 2 Cases With Clinical, Radiological, and Pathogenetic Evaluation
por: Chen, Lei, et al.
Publicado: (2019)

PROCEEDINGS OF LGMD days MEETING: Prognosis and Treatment in LGMD October 15-17, 2014 IRCCS "S. Camillo", Lido di Venezia (VE), Italy
Publicado: (2014)

Lithium chloride corrects weakness and myopathology in a preclinical model of LGMD1D
por: Findlay, Andrew R., et al.
Publicado: (2019)

HIV-1-Associated Neurocognitive Disorders: Is HLA-C Binding Stability to β(2)-Microglobulin a Missing Piece of the Pathogenetic Puzzle?
por: Zipeto, Donato, et al.
Publicado: (2018)

Novel mutation in TNPO3 causes congenital limb-girdle myopathy with slow progression
por: Vihola, Anna, et al.
Publicado: (2019)

The role of sleep in neuromuscular disorders
por: Angelini, Corrado I., et al.
Publicado: (2023)

A Journey with LGMD: From Protein Abnormalities to Patient Impact
por: Georganopoulou, Dimitra G., et al.
Publicado: (2021)

The Author Reply: Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations
por: Kim, Kitae, et al.
Publicado: (2018)

Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery
por: Carotti, Marcello, et al.
Publicado: (2020)

Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients
por: Nallamilli, Babi Ramesh Reddy, et al.
Publicado: (2018)

The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6
por: Fricke, Thomas, et al.
Publicado: (2013)

PATHOGENETIC MECHANISMS IN EXPERIMENTAL IMMUNE FEVER
por: Root, Richard K., et al.
Publicado: (1968)

Pathogenetic mechanisms of heatstroke and novel therapies
por: Bouchama, Abderrezak
Publicado: (2012)

Pathogenetic Mechanism of Procalcitonin in COVID-19
por: Wiedermann, Franz J
Publicado: (2021)

Melanosis of the Bladder: Possible Pathogenetic Mechanisms
por: Dupey, Justin E., et al.
Publicado: (2022)

An update on malignant tumor-related stiff person syndrome spectrum disorders: clinical mechanism, treatment, and outcomes
por: Peng, Yong, et al.
Publicado: (2023)

The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States
por: Reddy, Hemakumar M., et al.
Publicado: (2016)

Genetic Counseling and NGS Screening for Recessive LGMD2A Families
por: Strafella, Claudia, et al.
Publicado: (2020)

Enhancing LGMD-based model for collision prediction via binocular structure
por: Zheng, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bb8niae3rre0cvc9m5358u597o